These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28822703)

  • 1. Turning the screw even further to increase microparticle retention and ocular bioavailability of associated drugs: The bioadhesion goal.
    Rodríguez Villanueva J; Rodríguez Villanueva L
    Int J Pharm; 2017 Oct; 531(1):167-178. PubMed ID: 28822703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery.
    Singh M; Bharadwaj S; Lee KE; Kang SG
    J Control Release; 2020 Dec; 328():895-916. PubMed ID: 33069743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
    Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration.
    Maulvi FA; Shetty KH; Desai DT; Shah DO; Willcox MDP
    Int J Pharm; 2021 Oct; 608():121105. PubMed ID: 34537269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocrystal for ocular drug delivery: hope or hype.
    Sharma OP; Patel V; Mehta T
    Drug Deliv Transl Res; 2016 Aug; 6(4):399-413. PubMed ID: 27165145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties.
    Subrizi A; Del Amo EM; Korzhikov-Vlakh V; Tennikova T; Ruponen M; Urtti A
    Drug Discov Today; 2019 Aug; 24(8):1446-1457. PubMed ID: 30738982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular delivery of macromolecules.
    Kim YC; Chiang B; Wu X; Prausnitz MR
    J Control Release; 2014 Sep; 190():172-81. PubMed ID: 24998941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of in situ gelling systems for sustained topical ophthalmic delivery: state of the art and beyond.
    Destruel PL; Zeng N; Maury M; Mignet N; Boudy V
    Drug Discov Today; 2017 Apr; 22(4):638-651. PubMed ID: 28017837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Delivery for Ocular Allergy: Current Formulation Design Strategies and Future Perspectives.
    Regu VR; Swain RP; Subudhi BB
    Curr Pharm Des; 2023; 29(33):2626-2639. PubMed ID: 37936454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioactivation antioxidant and transglycating properties of N-acetylcarnosine autoinduction prodrug of a dipeptide L-carnosine in mucoadhesive drug delivery eye-drop formulation: powerful eye health application technique and therapeutic platform.
    Babizhayev MA
    Drug Test Anal; 2012 Jun; 4(6):468-85. PubMed ID: 21416634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ gel systems as 'smart' carriers for sustained ocular drug delivery.
    Agrawal AK; Das M; Jain S
    Expert Opin Drug Deliv; 2012 Apr; 9(4):383-402. PubMed ID: 22432690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advancemnts in Biodegradable Ocular Implants.
    Mittal S; Miranda O
    Curr Drug Deliv; 2018 Feb; 15(2):144-154. PubMed ID: 28482784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comprehensive Review on the Role of Polymers in Ocular Drug Delivery.
    Paramjot ; Wadhwa S; Sharma A; Singh SK; Vishwas S; Kumar R; Singh S; Dua K; Chellappan DK; Gupta G
    Curr Drug Deliv; 2024; 21(1):16-37. PubMed ID: 36627785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piroxicam bioadhesive ocular inserts: physicochemical characterization and evaluation in prostaglandin-induced inflammation.
    Gilhotra RM; Gilhotra N; Mishra DN
    Curr Eye Res; 2009 Dec; 34(12):1065-73. PubMed ID: 19958126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.
    Shen J; Lu GW; Hughes P
    Pharm Res; 2018 Sep; 35(11):217. PubMed ID: 30255364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Topical Ocular Drug Delivery.
    Yellepeddi VK; Palakurthi S
    J Ocul Pharmacol Ther; 2016 Mar; 32(2):67-82. PubMed ID: 26666398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contact lenses as drug-delivery systems: a promising therapeutic tool.
    Holgado MA; Anguiano-Domínguez A; Martín-Banderas L
    Arch Soc Esp Oftalmol (Engl Ed); 2020 Jan; 95(1):24-33. PubMed ID: 31420118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer approaches for optimal bioavailability of ocularly delivered drugs: review.
    Kesavan K; Balasubramaniam J; Kant S; Singh PN; Pandit JK
    Curr Drug Deliv; 2011 Mar; 8(2):172-93. PubMed ID: 21235476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the topical ocular pharmacokinetics of lyophilized cyclosporine A-loaded micelles: formulation, in vitro and in vivo studies.
    Yu Y; Chen D; Li Y; Yang W; Tu J; Shen Y
    Drug Deliv; 2018 Nov; 25(1):888-899. PubMed ID: 29631468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.